ライフサイエンスコーパス: vascular imaging

1 research, and positron emission tomographic vascular imaging.

2 hy and FCA among those subjects who received vascular imaging.

3 blood perfusion was reduced as documented by vascular imaging.

4 d specific educational components of CMR and vascular imaging.

5 use formal educational curricula for CMR and vascular imaging.

6 cell arteritis is most commonly diagnosed by vascular imaging.

7 ed the diagnostic and therapeutic aspects of vascular imaging.

8 ith tumors in host animals injected with the vascular imaging agent gadolinium also being enhanced le

9 Emerging evidence based on ultrasonographic vascular imaging and angiogenic biomarkers implicates an

10 d registry of patients with FMD confirmed by vascular imaging and currently enrolling at 14 participa

11 isplays favorable pharmacokinetics for early vascular imaging and enables specific detection of infla

12 a, Europe, and the USA, with early brain and vascular imaging and follow up.

13 has routinely involved punch skin biopsies, vascular imaging and graft appearance.

14 With ongoing advancements in noninvasive vascular imaging and high-throughput genomics, we have t

15 us contrast enhancement dramatically improve vascular imaging and resolution within the prostate.

16 the current training environment in CMR and vascular imaging and the recommendations of COCATS-2.

17 cardiovascular magnetic resonance (CMR) and vascular imaging and to quantify the magnitude of any ga

18 timodality imaging technology, molecular and vascular imaging, and clinical guidelines with appropria

19 hy, EF5 immunostaining, Hoechst fluorescence vascular imaging, and hematoxylin-and-eosin histology-we

20 ates some predictive value for hypertension, vascular imaging, and polymorphisms affecting components

21 This in vivo vascular imaging approach is valuable in monitoring norm

22 selection criteria, use of optimal brain and vascular imaging, appropriate devices for recanalization

23 ve imaging and clinical education, including vascular imaging as well as cardiac.

24 care networks, the question of the need for vascular imaging at the RHs remains unsolved, resulting

25 Use of iodinated contrast for vascular imaging can be associated with nephrotoxicity a

26 atheter manipulation, as well as specialized vascular imaging equipment.

27 ained renal ECM scaffolds were processed for vascular imaging, histology, and cell seeding to investi

28 otential use for CO2 as a contrast agent for vascular imaging in patients with suboptimal renal funct

29 Emergency vascular imaging, including arteriography and venography

30 r findings suggest that in certain subgroups vascular imaging, including collateral assessment, can p

31 Vascular imaging makes it possible to quantify the numbe

32 isk plaque in vivo; however, these important vascular imaging methods additionally promise great scie

33 Non-invasive vascular imaging methods that could be used to identify

34 of molecular probes for alternative in vivo vascular imaging modalities, but few options for genetic

35 ence tomography angiography is a noninvasive vascular imaging modality that clearly depicts the loopi

36 a prospective cohort evaluating the role of vascular imaging on cardiovascular risk prediction.

37 ptimal renal function who require definitive vascular imaging or therapy.

38 eld MSOT was found to be capable of clinical vascular imaging, providing visualization of major blood

39 Of 667 subjects, 525 had known vascular imaging results, and 53% of those (n=277) had a

40 label-free, high resolution, and wide-field vascular imaging, revealed the absence of both capillary

41 Vascular imaging should be mandated in future endovascul

42 troke-specialist assessment, urgent MRI, and vascular imaging should now be considered, with monitori

43 al animal studies, human biomarker data, and vascular imaging studies provide support for proceeding

44 Whether carotid ultrasound and other vascular imaging studies should be performed routinely f

45 Vascular imaging studies were performed at least yearly

46 e. punch skin biopsies, DSA and conventional vascular imaging studies) are inadequate for detecting t

47 isk factor assessment, as well as a complete vascular imaging study that was performed blinded to the

48 Electrophysiological studies and vascular imaging suggest an ON-limited infarct with subs

49 ing whole brain CT perfusion and concomitant vascular imaging, suggest that age has a differential ef

50 Conventional vascular imaging techniques for analysis of intracranial

51 to the widespread use of noninvasive in vivo vascular imaging techniques is the current lack of suita

52 Real-time vascular imaging that provides both anatomic and hemodyn

53 After a review of basic considerations in vascular imaging, the established methods for nonenhance

54 imaging platforms are available for targeted vascular imaging to acquire information on both anatomy

55 gy applications, including material science, vascular imaging, vaccine development, and targeted drug

56 Vascular imaging was not a requirement in the trials.

57 By fluorescent vascular imaging, we provide evidence that the vasculatu

58 Retinal vascular imaging with pvOCT provides accurate measuremen